Captura de pantalla 2026-06-19 a la(s) 11.45.06 a.m..png

Complete metabolic diagnosis in less than 30 minutes — right in your office.

MetriSense is the first rapid point-of-care test that simultaneously measures leptin, adiponectin, and insulin in a single sample. No lab. No waiting. Actionable results in the same appointment.

Request a demo

Technology developed in:

Metabolic diagnosis comes late

Detecting insulin resistance, metabolic syndrome, or subclinical inflammation currently requires a centralized laboratory, patient transport, and up to three weeks of waiting time. There is no commercially available rapid test that measures leptin or adiponectin in a portable format.

37%

of people with undiagnosed diabetes in Mexico

40%

of adults with metabolic syndrome

3 weeks

average lab result time

$4,675

MXN maximum cost per ELISA test

MetriSense brings advanced metabolic diagnostics directly to the doctor's office.

What does it measure?

How does it work?

Leptin: a marker of inflammation and satiety

Adiponectin: regulator of insulin sensitivity

Insulin: a direct indicator of metabolic resistance

LFA platform with fluorescent detection by europium particles (Eu³⁺). High-affinity antibodies capture all three biomarkers simultaneously. Results in less than 30 minutes.

10–20 minute training. No spin cycle. No special refrigeration required. Operable by non-specialized personnel.

No other portable device measures these three biomarkers on a single cassette.

With a single sample, in less than 30 minutes and without specialized infrastructure, the doctor obtains the patient's complete metabolic profile and makes preventive decisions in the same consultation.

Faster. More accessible. Just as accurate.

<30 min

56%+

2 months

results in the clinic

savings vs. laboratory

payback for the clinic

Frontier science + business execution.

Dr. Alejandro Cantón — CEO / EIR

Medical Doctor (MD) with 5 years in strategic management and GTM. Responsible for fundraising, marketing and institutional relations.

Dr. Katerina Kourentzi — CTO

20 years in LFA, design-for-manufacturing and regulatory documentation. Technical supervision of manufacturing and suppliers.

Dr. Mirna González — Lead Inventor

PhD in Biochemistry and Biotechnology · Tec de Monterrey. Developed and validated the LFA-europium platform.

Dr. Richard Willson — Scientific Advisor

University of Houston. LFA Specialist with experience in spin-offs with FDA clearance and international technology transfer.

Technology developed in:

Do you want to bring advanced metabolic diagnostics to your clinic?

We are currently in clinical pilot trials. If you are a physician, clinic administrator, distributor, or investor, please contact us.

Your information is protected in accordance with the Federal Law on the Protection of Personal Data Held by Private Parties.

MetriSense · Point-of-care metabolic diagnostics · Backed by Fill The Blank Innovation and Tecnológico de Monterrey

Product undergoing COFEPRIS Class II registration. Not available for commercial sale until approval is granted.